NPJ Parkinson's Disease最新文献

筛选
英文 中文
Independent serum metabolomics approaches identify disrupted glutamic acid and serine metabolism in Parkinson's disease patients. 独立的血清代谢组学方法鉴定帕金森病患者谷氨酸和丝氨酸代谢紊乱。
IF 8.2 1区 医学
NPJ Parkinson's Disease Pub Date : 2025-09-25 DOI: 10.1038/s41531-025-01126-5
Jacopo Gervasoni, Carmen Marino, Alberto Imarisio, Lavinia Santucci, Enza Napolitano, Tommaso Nuzzo, Isar Yahyavi, Micol Avenali, Michela Cicchinelli, Gabriele Buongarzone, Caterina Galandra, Marta Picascia, Manuela Grimaldi, Claudio Pacchetti, Francesco Errico, Anna Maria D'Ursi, Andrea Urbani, Enza Maria Valente, Alessandro Usiello
{"title":"Independent serum metabolomics approaches identify disrupted glutamic acid and serine metabolism in Parkinson's disease patients.","authors":"Jacopo Gervasoni, Carmen Marino, Alberto Imarisio, Lavinia Santucci, Enza Napolitano, Tommaso Nuzzo, Isar Yahyavi, Micol Avenali, Michela Cicchinelli, Gabriele Buongarzone, Caterina Galandra, Marta Picascia, Manuela Grimaldi, Claudio Pacchetti, Francesco Errico, Anna Maria D'Ursi, Andrea Urbani, Enza Maria Valente, Alessandro Usiello","doi":"10.1038/s41531-025-01126-5","DOIUrl":"10.1038/s41531-025-01126-5","url":null,"abstract":"<p><p>Whether distinct blood metabolomic profiles can distinguish Parkinson's disease (PD) patients from healthy controls (HC) is still a matter of debate. Here, we employed ¹H-NMR and UPLC/MS analyses on serum samples from a cohort of PD patients and HC. Compared to HC, PD patients showed: (1) higher glutamine, serine, pyruvate and lower α-ketoglutarate levels (<sup>1</sup>H-NMR); (2) higher glycine and lower glutamic acid concentrations (UPLC/MS). Several pathways associated with amino acids, mitochondrial and antioxidant metabolism emerged as dysregulated in PD. Our findings highlight a prominent disruption of cellular bioenergetic pathways and amino acid homeostasis in PD.</p>","PeriodicalId":19706,"journal":{"name":"NPJ Parkinson's Disease","volume":"11 1","pages":"274"},"PeriodicalIF":8.2,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12462461/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145150359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genome-wide association study of REM sleep behavior disorder in Parkinson's disease. 帕金森病快速眼动睡眠行为障碍的全基因组关联研究
IF 8.2 1区 医学
NPJ Parkinson's Disease Pub Date : 2025-09-25 DOI: 10.1038/s41531-025-01078-w
Yuri L Sosero, Karl Heilbron, Pierre Fontanillas, Lucy Norcliffe-Kaufmann, Eric Yu, Uladzislau Rudakou, Jennifer A Ruskey, Kathryn Freeman, Farnaz Asayesh, Kajsa A Brolin, Maria Swanberg, Huw R Morris, Lesley Wu, Raquel Real, Lasse Pihlstrøm, Manuela Tan, Thomas Gasser, Kathrin Brockmann, Hui Liu, Michele T M Hu, Donald G Grosset, Simon J G Lewis, John B Kwok, Pau Pastor, Ignacio Alvarez, Matej Skorvanek, Alexandra Lackova, Miriam Ostrozovicova, Mie Rizig, Lynne Krohn, Ziv Gan-Or
{"title":"Genome-wide association study of REM sleep behavior disorder in Parkinson's disease.","authors":"Yuri L Sosero, Karl Heilbron, Pierre Fontanillas, Lucy Norcliffe-Kaufmann, Eric Yu, Uladzislau Rudakou, Jennifer A Ruskey, Kathryn Freeman, Farnaz Asayesh, Kajsa A Brolin, Maria Swanberg, Huw R Morris, Lesley Wu, Raquel Real, Lasse Pihlstrøm, Manuela Tan, Thomas Gasser, Kathrin Brockmann, Hui Liu, Michele T M Hu, Donald G Grosset, Simon J G Lewis, John B Kwok, Pau Pastor, Ignacio Alvarez, Matej Skorvanek, Alexandra Lackova, Miriam Ostrozovicova, Mie Rizig, Lynne Krohn, Ziv Gan-Or","doi":"10.1038/s41531-025-01078-w","DOIUrl":"10.1038/s41531-025-01078-w","url":null,"abstract":"<p><p>REM sleep behavior disorder (RBD), is a prodromal synucleinopathy affecting a subset of Parkinson's disease (PD) patients and associated with neuropsychiatric symptoms. This study compared the genetic profiles of 13,020 PD patients with probable RBD (PD + RBD) and 5403 without (PD-RBD) using genome-wide association study (GWAS). RBD was assessed by questionnaires or self-reporting. Potential genetic correlations between neuropsychiatric traits and PD + RBD were assessed using linkage disequilibrium score regression. The top variant in the SNCA locus was associated with PD + RBD (rs10005233-T, OR = 1.21, 95% CI = 1.16-1.27, p = 1.81e-15). PD risk variants in SNCA (rs5019538-G, OR = 0.85, 95% CI = 0.81-0.89, p = 2.46e-10; rs356182-G, OR = 0.89, 95% CI = 0.84-0.95, p = 0.0001) and LRRK2 loci (rs34637584, OR = 0.41, 95% CI = 0.28-0.61, p = 1.04e-5) were associated with reduced PD + RBD risk. A suggestive genetic correlation between attention deficit hyperactivity disorder and PD + RBD was observed but was not statistically significant after correction. These findings highlight genetic distinctions between PD + RBD and PD-RBD, offering insights into PD stratification and potential subtype-specific treatments.</p>","PeriodicalId":19706,"journal":{"name":"NPJ Parkinson's Disease","volume":"11 1","pages":"272"},"PeriodicalIF":8.2,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12462436/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145150337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predicting Parkinson's disease and its progression based on radiomics in T1-weight images and α‑synuclein in cerebrospinal fluid. 基于t1体重图像和脑脊液α -突触核蛋白放射组学预测帕金森病及其进展。
IF 8.7 1区 医学
NPJ Parkinson's Disease Pub Date : 2025-09-25 DOI: 10.1038/s41531-025-01097-7
Xu Zhang,Hui Li,Xiaona Xia,Jiaojiao Wu,Feng Shi,Cuiping Zhao,Xiangshui Meng,Qingguo Ren
{"title":"Predicting Parkinson's disease and its progression based on radiomics in T1-weight images and α‑synuclein in cerebrospinal fluid.","authors":"Xu Zhang,Hui Li,Xiaona Xia,Jiaojiao Wu,Feng Shi,Cuiping Zhao,Xiangshui Meng,Qingguo Ren","doi":"10.1038/s41531-025-01097-7","DOIUrl":"https://doi.org/10.1038/s41531-025-01097-7","url":null,"abstract":"This study aimed to develop a radiomics model that can predict Parkinson's disease (PD) and its progression of using T1-weighted images (T1WI), and to evaluate the prediction performance of a multimodal model incorporating clinical factors. We selected all participants from the Parkinson's Progression Markers Initiative (PPMI) (n = 205) database and Qilu Hospital of Shandong University (Qingdao) (n = 60). The patients were tracked over 4-5 years via Hoehn-Yahr Scale (HYS) and categorized into stable PD (SPD: HYS unchanged) and progression PD (PPD: HYS increase). Participants from the PPMI database were randomly divided into a training dataset and an internal testing dataset to construct radiomics models, which were validated by the Qilu Hospital database as an independent testing dataset. Only participants from the PPMI database had cerebrospinal fluid (CSF) α‑synuclein (α-syn) data, which were used to establish a combined model. The radiomics-based classifier for healthy controls (HC) and PD achieved areas under the receiver operating characteristic curves (AUROCs) of 0.787 and 0.746 in the internal and independent testing datasets, respectively, while the AUROCs were 0.857 and 0.802 in predicting SPD and PPD, respectively. Moreover, integrating CSF total α-syn in the combined model enhanced the predictive performance, with AUROC of 0.890, sensitivity of 0.846 and specificity of 0.857 for HC vs. PD, and AUROC of 0.939, sensitivity of 0.917 and specificity of 0.933 for SPD vs. PPD in the internal testing dataset. The current research presented evidence that radiomics utilizing conventional T1WI can predict the clinical stages of PD and that the efficacy of the multimodal model can be boosted by combining radiomics with CSF total α‑syn.","PeriodicalId":19706,"journal":{"name":"NPJ Parkinson's Disease","volume":"29 1","pages":"273"},"PeriodicalIF":8.7,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145140305","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Direct disassembly of α-syn preformed fibrils into α-syn monomers by an all-D-peptide. 通过全d肽直接将α-syn预制原纤维分解成α-syn单体。
IF 8.2 1区 医学
NPJ Parkinson's Disease Pub Date : 2025-09-22 DOI: 10.1038/s41531-025-01132-7
Marc Sevenich, Ian Gering, Bettina Kass, Madita Vollmer, Selma Aghabashlou Saisan, Markus Tusche, Tatsiana Kupreichyk, Thomas Pauly, Matthias Stoldt, Wolfgang Hoyer, Antje Willuweit, Janine Kutzsche, Nils-Alexander Lakomek, Luitgard Nagel-Steger, Lothar Gremer, Gültekin Tamgüney, Jeannine Mohrlüder, Dieter Willbold
{"title":"Direct disassembly of α-syn preformed fibrils into α-syn monomers by an all-D-peptide.","authors":"Marc Sevenich, Ian Gering, Bettina Kass, Madita Vollmer, Selma Aghabashlou Saisan, Markus Tusche, Tatsiana Kupreichyk, Thomas Pauly, Matthias Stoldt, Wolfgang Hoyer, Antje Willuweit, Janine Kutzsche, Nils-Alexander Lakomek, Luitgard Nagel-Steger, Lothar Gremer, Gültekin Tamgüney, Jeannine Mohrlüder, Dieter Willbold","doi":"10.1038/s41531-025-01132-7","DOIUrl":"10.1038/s41531-025-01132-7","url":null,"abstract":"<p><p>A hallmark of Parkinson's disease (PD) is the progressive neurodegeneration associated with soluble oligomeric and fibrillar forms of misfolded α-synuclein (α-syn). In this study, all-D-enantiomeric peptide ligands are presented that bind monomeric α-syn with high affinity, stabilize its physiological monomeric status, prevent aggregation and dissolve existing aggregates. This \"antiprionic\" mode of action directly targets pathogenic aggregated particles. Using mirror-image phage display on D-enantiomeric full-length α-syn, SVD-1 and SVD-1a were identified, showing a delay of aggregation and reduction of aggregate formation in both de novo and seeded models. Picomolar KDs were confirmed by SPR, where a highly dynamic interaction mode was verified by PRE-NMR. SVD-1a also reduced the toxicity and intracellular seeding of α-syn fibrils in cell culture by disassembling them into monomers, as confirmed by atomic force microscopy and dynamic light scattering. These results support SVD-1a as a promising lead compound for the treatment of Parkinson's disease.</p>","PeriodicalId":19706,"journal":{"name":"NPJ Parkinson's Disease","volume":"11 1","pages":"271"},"PeriodicalIF":8.2,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12454639/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145125697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Methodological validation of Miro1 retention as a candidate Parkinson’s disease biomarker Miro1保留作为候选帕金森病生物标志物的方法学验证
IF 8.7 1区 医学
NPJ Parkinson's Disease Pub Date : 2025-09-15 DOI: 10.1038/s41531-025-01115-8
Layla Drwesh, Giuseppe Arena, Daniel J. Merk, Daniele Ferrante, Vyron Gorgogietas, Thomas Gasser, Anne Grünewald, Patrick May, Kathrin Brockmann, Rejko Krüger, Richard Wüst, Christian Johannes Gloeckner, Julia C. Fitzgerald
{"title":"Methodological validation of Miro1 retention as a candidate Parkinson’s disease biomarker","authors":"Layla Drwesh, Giuseppe Arena, Daniel J. Merk, Daniele Ferrante, Vyron Gorgogietas, Thomas Gasser, Anne Grünewald, Patrick May, Kathrin Brockmann, Rejko Krüger, Richard Wüst, Christian Johannes Gloeckner, Julia C. Fitzgerald","doi":"10.1038/s41531-025-01115-8","DOIUrl":"https://doi.org/10.1038/s41531-025-01115-8","url":null,"abstract":"<p>Mitochondrial markers help stratify Parkinson’s disease (PD) patients. We use high-throughput blotting to quantify Miro1, Mfn2, and VDAC levels in fibroblasts, blood cells, and iPSC-derived neurons. Miro1 is specifically retained in PD cells but degraded in healthy ones after mitochondrial depolarization. We correlate Miro1 retention scores with pathogenic mutations, genetic background, age, and clinical data. This scalable assay and quantifiable score for mitochondrial-PD support biomarker development and pharmacological screening.</p><figure></figure>","PeriodicalId":19706,"journal":{"name":"NPJ Parkinson's Disease","volume":"71 1","pages":""},"PeriodicalIF":8.7,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145068060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Author Correction: Patterns of cerebellar cortex hypermetabolism on motor and cognitive functions in PD. 作者更正:PD患者小脑皮质高代谢模式对运动和认知功能的影响。
IF 8.2 1区 医学
NPJ Parkinson's Disease Pub Date : 2025-08-31 DOI: 10.1038/s41531-025-01131-8
Wen-Hua Ren, Bin Chen, Jiu-Qin He, Yu-Meng Qi, Ya-Yun Yan, Shu-Xian Jin, Ying Chang
{"title":"Author Correction: Patterns of cerebellar cortex hypermetabolism on motor and cognitive functions in PD.","authors":"Wen-Hua Ren, Bin Chen, Jiu-Qin He, Yu-Meng Qi, Ya-Yun Yan, Shu-Xian Jin, Ying Chang","doi":"10.1038/s41531-025-01131-8","DOIUrl":"10.1038/s41531-025-01131-8","url":null,"abstract":"","PeriodicalId":19706,"journal":{"name":"NPJ Parkinson's Disease","volume":"11 1","pages":"269"},"PeriodicalIF":8.2,"publicationDate":"2025-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12399739/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144963870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Elevated hexosylceramides in Parkinson’s disease cause gene upregulations in neurons mimicking responses to pathogens 帕金森病中升高的己糖神经酰胺引起神经元对病原体反应的基因上调
IF 8.7 1区 医学
NPJ Parkinson's Disease Pub Date : 2025-08-30 DOI: 10.1038/s41531-025-01114-9
Luisa Franck, Lisa Hahnefeld, Lucie Valek, Katharina Klatt-Schreiner, Annett Wilken-Schmitz, Mohamad Wessam Alnouri, Sandra Trautmann, Marc-Philipp Weyer, Dominique Thomas, Robert Gurke, Stefan Offermanns, Gerd Geisslinger, Irmgard Tegeder
{"title":"Elevated hexosylceramides in Parkinson’s disease cause gene upregulations in neurons mimicking responses to pathogens","authors":"Luisa Franck, Lisa Hahnefeld, Lucie Valek, Katharina Klatt-Schreiner, Annett Wilken-Schmitz, Mohamad Wessam Alnouri, Sandra Trautmann, Marc-Philipp Weyer, Dominique Thomas, Robert Gurke, Stefan Offermanns, Gerd Geisslinger, Irmgard Tegeder","doi":"10.1038/s41531-025-01114-9","DOIUrl":"https://doi.org/10.1038/s41531-025-01114-9","url":null,"abstract":"<p>Parkinson’s Disease (PD) is driven by pathological aggregates of alpha-synuclein (αSyn), whose formation is facilitated by impaired glycosphingolipid metabolism via acidic glucocerebrosidase (GCase). We investigated glucosylceramide (GlcCer) accumulation in human, mouse, and cellular PD models. Lipidomic analyses revealed elevated plasma GlcCer, especially GlcCer24:1, and a shift in phosphatidylcholine (PC) species in PD patients. PD patient skin fibroblasts accumulated more GlcCer under lysosomal stress. GlcCer and sulfatides (SHexCer) were increased in Pink1<sup>−/−</sup>SNCA<sup>A53T</sup> PD mouse brains, and HT22 neurons exposed to preformed αSyn fibrils accumulated GlcCer and ceramides. GlcCer24:1 enhanced fibril toxicity, but had no direct or indirect effect on G-protein coupled receptors. RNAseq of GlcCer24:1-treated dorsal root ganglion neurons showed upregulation of glycolipid response genes, similar to pathogen-related signaling. These data indicate extracellular GlcCer is elevated in PD and triggers innate immune responses in sensory neurons.</p>","PeriodicalId":19706,"journal":{"name":"NPJ Parkinson's Disease","volume":"93 1","pages":""},"PeriodicalIF":8.7,"publicationDate":"2025-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144919173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lrrk2 G2019S mutation incites increased cell-intrinsic neutrophil effector functions and intestinal inflammation in a model of infectious colitis Lrrk2 G2019S突变在感染性结肠炎模型中刺激细胞内中性粒细胞效应物功能增加和肠道炎症
IF 8.7 1区 医学
NPJ Parkinson's Disease Pub Date : 2025-08-29 DOI: 10.1038/s41531-025-01077-x
Jessica Pei, Nathalia L. Oliveira, Sherilyn J. Recinto, Alexandra Kazanova, Celso M. Queiroz-Junior, Ziyi Li, Katalina Couto, Susan Westfall, Ahmed M. Fahmy, Camila Tiefensee-Ribeiro, Irah L. King, Austen J. Milnerwood, Michel Desjardins, Ajitha Thanabalasuriar, Jo Anne Stratton, Samantha Gruenheid
{"title":"Lrrk2 G2019S mutation incites increased cell-intrinsic neutrophil effector functions and intestinal inflammation in a model of infectious colitis","authors":"Jessica Pei, Nathalia L. Oliveira, Sherilyn J. Recinto, Alexandra Kazanova, Celso M. Queiroz-Junior, Ziyi Li, Katalina Couto, Susan Westfall, Ahmed M. Fahmy, Camila Tiefensee-Ribeiro, Irah L. King, Austen J. Milnerwood, Michel Desjardins, Ajitha Thanabalasuriar, Jo Anne Stratton, Samantha Gruenheid","doi":"10.1038/s41531-025-01077-x","DOIUrl":"https://doi.org/10.1038/s41531-025-01077-x","url":null,"abstract":"<p>Parkinson’s Disease (PD) is a neurodegenerative disorder often preceded by gastrointestinal dysfunction. Mutations in leucine-rich repeat kinase 2 (<i>LRRK2</i>) are known risk factors for both PD and inflammatory bowel disease (IBD), suggesting a link between PD and the gastrointestinal tract. Using single-cell RNA-sequencing and spectral flow cytometry, we demonstrated that the <i>Lrrk2</i> Gly2019Ser (G2019S) mutation is associated with an increased neutrophil presence in the colonic lamina propria during <i>Citrobacter rodentium</i> infection. This concurred with a Th17 skewing, upregulated <i>Il17a</i>, and greater colonic pathology during infection. In vitro experiments showed enhanced kinase-dependent neutrophil chemotaxis and neutrophil extracellular trap (NET) formation in <i>Lrrk2</i> G2019S mice compared to wild-type counterparts. Our results add to the understanding of LRRK2-driven immune cell dysregulation and its contribution to PD, offering insights into potential biomarkers for early diagnosis and intervention in PD.</p>","PeriodicalId":19706,"journal":{"name":"NPJ Parkinson's Disease","volume":"11 1","pages":""},"PeriodicalIF":8.7,"publicationDate":"2025-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144919116","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chronic adaptive deep brain stimulation for Parkinson’s disease: clinical outcomes and programming strategies 慢性适应性脑深部刺激治疗帕金森病:临床结果和规划策略
IF 8.7 1区 医学
NPJ Parkinson's Disease Pub Date : 2025-08-29 DOI: 10.1038/s41531-025-01124-7
Johannes L. Busch, Jonathan Kaplan, Jennifer K. Behnke, Victoria S. Witzig, Luisa Drescher, Jeroen G. V. Habets, Andrea A. Kühn
{"title":"Chronic adaptive deep brain stimulation for Parkinson’s disease: clinical outcomes and programming strategies","authors":"Johannes L. Busch, Jonathan Kaplan, Jennifer K. Behnke, Victoria S. Witzig, Luisa Drescher, Jeroen G. V. Habets, Andrea A. Kühn","doi":"10.1038/s41531-025-01124-7","DOIUrl":"https://doi.org/10.1038/s41531-025-01124-7","url":null,"abstract":"<p>Adaptive deep brain stimulation (DBS) dynamically adjusts stimulation amplitude based on neurophysiological feedback and may alleviate residual motor fluctuations in patients with Parkinson’s disease. However, potential clinical benefits and programming strategies remain poorly understood. We programmed eight patients with Parkinson’s disease on commercially available Dual Threshold adaptive DBS based on subthalamic beta power. Symptom severity was evaluated at home using ecological momentary assessments during two weeks of both continuous and adaptive DBS. Patients were not blinded to the stimulation mode. On the group level, overall well-being significantly improved with adaptive DBS (<i>p</i> = 0.007), and there was a non-significant trend toward enhanced general movement (<i>p</i> = 0.058). Within-subject analysis showed a significant improvement in overall well-being and general movement in three of eight patients. Six of eight patients chose to remain on adaptive DBS. Programming challenges included biomarker selection, threshold definition, and artifact-related maladaptation, for which targeted strategies are reported. Our findings support adaptive DBS as a potential option for selected Parkinson’s disease patients with persistent motor symptoms on continuous DBS. We propose a three-step programming approach to guide clinical implementation of adaptive DBS.</p>","PeriodicalId":19706,"journal":{"name":"NPJ Parkinson's Disease","volume":"55 1","pages":""},"PeriodicalIF":8.7,"publicationDate":"2025-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144915366","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Systematic review of prognostic models in Parkinson’s disease 帕金森病预后模型的系统综述
IF 8.7 1区 医学
NPJ Parkinson's Disease Pub Date : 2025-08-29 DOI: 10.1038/s41531-025-01112-x
Yan Li, Millie McDonald-Webb, David J. McLernon, Carl E. Counsell, Angus D. Macleod
{"title":"Systematic review of prognostic models in Parkinson’s disease","authors":"Yan Li, Millie McDonald-Webb, David J. McLernon, Carl E. Counsell, Angus D. Macleod","doi":"10.1038/s41531-025-01112-x","DOIUrl":"https://doi.org/10.1038/s41531-025-01112-x","url":null,"abstract":"<p>Predicting outcomes for people with Parkinson’s (PwP) can enable better information provision, personalised treatments, and enhanced trial design. It is unclear what prognostic models are optimal for use. We systematically reviewed previously published prognostic models for PwP, assessed quality, and made recommendations. We searched MEDLINE and EMBASE for studies developing/validating models predicting clinical outcomes in PwP. We assessed risk of bias and applicability using the PROBAST tool. We screened 1024 references and identified 25 studies (41 prognostic models). The most common outcomes were falls (11 studies), dementia (7) and motor complications (4). Most models made short-term predictions (60% ≤2 years). All studies had concerns about bias, e.g., inadequate population details (<i>n</i> = 16), suboptimal methods for missing data (<i>n</i> = 21), and no external validation (<i>n</i> = 22). 13 models had sufficient information to be used in practice. Further development and validation of prognostic models is needed which follows existing guidelines to reduce risk of bias.</p>","PeriodicalId":19706,"journal":{"name":"NPJ Parkinson's Disease","volume":"10 1","pages":""},"PeriodicalIF":8.7,"publicationDate":"2025-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144915365","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信